Dr. Christopher Bryce Johnson, MD, PhD

Dr. Johnson practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Johnson's NPI, 1619330289, was assigned on March 31, 2016. Dr. Johnson graduated from University of South Carolina School of Medicine in 2016. Dr. Johnson holds Virginia license 1013962836.

Dr. Johnson's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Johnson's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Johnson is also affiliated with Inova Fairfax Hospital. The medical group on file is Radiation Oncology Associates of Northern Virginia. Dmand AI also links Dr. Johnson to 4 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Johnson's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Johnson is licensed in Virginia.

CMS data shows 3,483 Medicare services from Dr. Johnson across 18 procedure codes in 2024, for 600 Medicare patients. Medicare paid $321,796 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 600 Medicare patients who saw Dr. Johnson in 2024. The largest group is 65 to 74, with 282 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Johnson's median patient age at 67, with 45% women.

In 2024, Dr. Johnson wrote 182 Medicare Part D claims for 70 patients. 97% of them were for generic drugs. CMS names the drug for 130 of them, across 6 drugs with 11 or more claims each, at $1,113 in total drug cost. In 2023, CMS named 36 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Johnson for performance year 2024, reported as part of a group. Dr. Johnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Johnson as offering telehealth.

CMS Open Payments shows 12 general payments to Dr. Johnson from 7 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 86% of the total. AstraZeneca Pharmaceuticals LP paid the most, $6,080.

Dr. Johnson graduated from University of South Carolina School of Medicine in 2016.